Annals of Hepato-Biliary-Pancreatic Surgery

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2508-5859   pISSN 2508-5778

Table. 1.

Table. 1.

Demographics and perioperative details

PVR (n=35) No PVR (n=200) p value
Age (years, mean±SD) 63.9±9.2 64.3±8.4 0.823
Sex (male/female (N, %)) 20 (57.1)/15 (42.9) 132 (66)/68 (34) 0.341
BMI (kg/m2, mean±SD) 23.8±5.4 24.1±5.3 0.403
ASA class 1/2/3 (%) 8/22/3 40/152/8 0.733
Follow up duration (months, mean±SD) 34.4±31.6 40.1±33.4 0.355
Comorbidity (N, %)
Cardiovascular disease 14 (40.0) 92 (46.0) 0.514
Diabetes mellitus 6 (17.1) 50 (25.0) 0.308
Tuberculosis 2 (5.7) 10 (5.0) 0.632
Chronic liver disease 1 (2.8) 6 (3.0) 0.768
Previous abdominal surgery 3 (8.6) 33 (16.5) 0.179
PBD (N, %) 30 (85.7) 123 (61.5) 0.006
Preoperative PVE (N, %) 8 (22.8) 37 (18.5) 0.642
Preoperative laboratory test (mean±SD)
Hb (g/dl, mean±SD) 12.2±1.4 12.4±1.6 0.568
Albumin (g/dl, mean±SD) 3.8±0.3 3.7±0.4 0.470
T.Bil (mg/ml) 2.6±2.4 2.3±3.2 0.625
CEA (ng/ml) 3.3±2.3 2.5±2.2 0.358
CA 19-9 (U/ml) 946.9±1969.9 392.1±1489.3 0.066
Adjuvant treatment (N, %) 10 (28.6) 55 (27.5) 0.460
Operating time (min±SD) 432.0±79.1 404.1±89.2 0.150
EBL (ml, mean±SD) 1143.2±1034.5 688.0±442.3 <0.001
Right/Left hepatectomy (N, %) 33 (94.3)/2 (5.7) 144 (72)/56 (28) 0.001
Caudate lobectomy (N, %) 34 (97.1) 189 (94.5) 0.700
Positive resection margin (N, %)a 2 (5.7) 23 (11.5) 0.386
T stage 1/2/3 (N, %)b 1 (2.8)/20 (57.2)/14 (40) 25 (12.5)/151 (75.5)/24 (12) <0.001
Tumor size (cm, mean±SD) 3.3±1.4 3.1±1.7 0.586
Node metastasis (N, %) 21 (60.0) 56 (28.0) <0.001
Differentiation (N, %) 0.498
Well 8 (22.8) 28 (14)
Moderate 16 (45.7) 110 (55.0)
Poor 10 (28.6) 53 (26.5)
Perineural invasion (N, %) 13 (37.1) 62 (31.0) 0.225
Lymphovascular invasion (N, %) 32 (91.4) 142 (71.0) 0.065
30-day mortality (N, %) 1 (2.9) 2 (1.0) 0.394
Moderate to severe complication (≥C-D grade 3) (N, %) 12 (34.3) 68 (35.0) 0.875
General complication (N, %)
Cardiovascular 0 (0) 2 (1.0) 0.933
Pulmonary 4 (11.4) 17 (8.5) 0.810
Cerebrovascular 0 (0) 2 (1.0) 0.933
Renal failure 2 (5.7) 8 (4.0) 0.842
Procedure related complication (N, %)
Portal vein thrombosis 1 (2.8) 3 (1.5) 0.910
Postoperative liver failure 2 (5.7) 3 (1.5) 0.284
Bile leak 1 (2.8) 5 (2.5) 0.765
Bleeding 1 (2.8) 2 (1.0) 0.392
Intra-abdominal fluid collection 8 (22.9) 45 (22.5) 0.872
Intra-abdominal abscess 1 (2.8) 9 (4.5) 0.336
Wound problem 10 (28.6) 52 (26.0) 0.510

aResection margin positive means invasive carcinoma at margin

bAccording to AJCC 7th edition

BMI, body mass index; PBD, preoperative bile drainage; PVE, portal vein embolization; T. bili, total bilirubin; CEA, carcinoembryonic antigen; CA19-9, cancer antigen 19-9; EBL, estimated blood loss; C-D grade, Clavien-Dindo classification

Ann Hepatobiliary Pancreat Surg 2021;25:221-9 https://doi.org/10.14701/ahbps.2021.25.2.221
© 2021 Ann Hepatobiliary Pancreat Surg